{"id":321508,"date":"2026-04-20T05:05:35","date_gmt":"2026-04-19T23:35:35","guid":{"rendered":"https:\/\/ebiztoday.news\/?p=321508"},"modified":"2026-04-20T05:05:35","modified_gmt":"2026-04-19T23:35:35","slug":"bringing-ai-driven-protein-design-tools-to-biologists-in-all-places-mit-news","status":"publish","type":"post","link":"https:\/\/ebiztoday.news\/index.php\/2026\/04\/20\/bringing-ai-driven-protein-design-tools-to-biologists-in-all-places-mit-news\/","title":{"rendered":"Bringing AI-driven protein-design tools to biologists in all places | MIT News"},"content":{"rendered":"
\n

Artificial intelligence is already proving it may well speed up drug development and improve our understanding of disease. But to show AI into novel treatments we want to get the most recent, strongest models into the hands of scientists.<\/p>\n

The issue is that almost all scientists aren\u2019t machine-learning experts. Now the corporate OpenProtein.AI helps scientists stay on the innovative of AI with a no-code platform that provides them access to powerful foundation models and a collection of tools for designing proteins, predicting protein structure and performance, and training models.<\/p>\n

The corporate, founded by Tristan Bepler PhD \u201920 and former MIT associate professor Tim Lu PhD \u201907, is already equipping researchers in pharmaceutical and biotech firms of all sizes with its tools, including internally developed foundation models for protein engineering. OpenProtein.AI also offers its platform to scientists in academia at no cost.<\/p>\n

\u201cIt\u2019s a very exciting time right away because these models cannot only make protein engineering more efficient \u2014 which shortens development cycles for therapeutics and industrial uses \u2014 they may also enhance our ability to design latest proteins with specific traits,\u201d Bepler says. \u201cWe\u2019re also excited about applying these approaches to non-protein modalities. The massive picture is we\u2019re making a language for describing biological systems.\u201d<\/p>\n

Advancing biology with AI<\/strong><\/p>\n

Bepler got here to MIT in 2014 as a part of the Computational and Systems Biology PhD Program, studying under Bonnie Berger, MIT\u2019s Simons Professor of Applied Mathematics. It was there that he realized how little we understand in regards to the molecules that make up the constructing blocks of biology.<\/p>\n

\u201cWe hadn\u2019t characterised biomolecules and proteins well enough to create good predictive models of what, say, a complete genome circuit will do, or how a protein interaction network will behave,\u201d Bepler recalls. \u201cIt got me curious about understanding proteins at a more fine-grained level.\u201d<\/p>\n

Bepler began exploring ways to predict the chains of amino acids that make up proteins by analyzing evolutionary data. This was before Google released AlphaFold, a strong prediction model for protein structure. The work led to one in every of the primary generative AI models for understanding and designing proteins \u2014 what the team calls a protein language model.<\/p>\n

\u201cI used to be really excited in regards to the classical framework of proteins and the relationships between their sequence, structure, and performance. We don\u2019t understand those links well,\u201d Bepler says. \u201cSo how could we use these foundation models to skip the \u2018structure\u2019 component and go straight from sequence to operate?\u201d<\/p>\n

After earning his PhD in 2020, Bepler entered Lu\u2019s lab in MIT\u2019s Department of Biological Engineering as a postdoc.<\/p>\n

\u201cThis was across the time when the thought of integrating AI with biology was starting to choose up,\u201d Lu recalls. \u201cTristan helped us construct higher computational models for biologic design. We also realized there\u2019s a disconnect between probably the most cutting-edge tools available and the biologists, who would love to make use of these items but don\u2019t know the best way to code. OpenProtein got here from the thought of broadening access to those tools.\u201d<\/p>\n

Bepler had worked on the forefront of AI as a part of his PhD. He knew the technology could help scientists speed up their work.<\/p>\n

\u201cWe began with the thought to construct a general-purpose platform for doing machine learning-in-the-loop protein engineering,\u201d Bepler says. \u201cWe wanted to construct something that was user friendly because machine-learning ideas are form of esoteric. They require implementation, GPUs, fine-tuning, designing libraries of sequences. Especially at the moment, it was quite a bit for biologists to learn.\u201d<\/p>\n

OpenProtein\u2019s platform, in contrast, features an intuitive web interface for biologists to upload data and conduct protein engineering work with machine learning. It incorporates a range of open-source models, including PoET, OpenProtein\u2019s flagship protein language model.<\/p>\n

PoET, short for Protein Evolutionary Transformer, was trained on protein groups to generate sets of related proteins. Bepler and his collaborators showed it could generalize about evolutionary constraints on proteins and incorporate latest information on protein sequences without retraining, allowing other researchers so as to add experimental data to enhance the model.<\/p>\n

\u201cResearchers can use their very own data to coach models and optimize protein sequences, after which they’ll use our other tools to investigate those proteins,\u201d Bepler says. \u201cPersons are generating libraries of protein sequences in silico [on computers] after which running them through predictive models to get validation and structural predictors. It\u2019s mainly a no-code front-end, but we even have APIs for individuals who wish to access it with code.\u201d<\/p>\n

The models help researchers design proteins faster, then determine which of them are promising enough for further lab testing. Researchers may also input proteins of interest, and the models can generate latest ones with similar properties.<\/p>\n

Since its founding, OpenProtein\u2019s team has continued so as to add tools to its platform for researchers no matter their lab size or resources.<\/p>\n

\u201cWe\u2019ve tried really hard to make the platform an open-ended toolbox,\u201d Bepler says. \u201cIt has specific workflows, nevertheless it\u2019s not tied specifically to 1 protein function or class of proteins. Considered one of the nice things about these models is that they are superb at understanding proteins broadly. They learn in regards to the whole space of possible proteins.\u201d<\/p>\n

Enabling the subsequent generation of therapies<\/strong><\/p>\n

The massive pharmaceutical company Boehringer Ingelheim began using OpenProtein\u2019s platform in early 2025. Recently, the businesses announced an expanded collaboration that can see OpenProtein\u2019s platform and models embedded into Boehringer Ingelheim\u2019s work because it engineers proteins to treat diseases like cancer and autoimmune or inflammatory conditions.<\/p>\n

Last yr, OpenProtein also released a new edition of its protein language model, PoET-2, that outperforms much larger models while using a small fraction of the computing resources and experimental data.<\/p>\n

\u201cWe really need to resolve the query of how we describe proteins,\u201d Bepler says. \u201cWhat\u2019s the meaningful, domain-specific language of protein constraints we use as we generate them?\u00a0<\/strong>How can we herald more evolutionary constraints? How can we describe an enzymatic response a protein carries out such that a model can generate sequences to try this response?\u201d<\/p>\n

Moving forward,\u00a0<\/strong>the founders are hoping to make models that consider the changing, interconnected nature of protein function.<\/p>\n

\u201cThe world I’m enthusiastic about goes beyond protein binding events to make use of these models to predict and design dynamic features, where the protein has to have interaction two, three, or 4 biological mechanisms at the identical time, or change its function after binding,\u201d says Lu, who currently serves in an advisory role for the corporate.<\/p>\n

As progress in AI races forward, OpenProtein continues to see its mission as giving scientists one of the best tools to develop latest treatments faster.<\/p>\n

\u201cAs work gets more complex, with approaches incorporating things like protein logic and dynamic therapies, the present experimental toolsets grow to be limiting,\u201d Lu says. \u201cIt\u2019s really vital to create open ecosystems around AI and biology. There\u2019s a risk that AI resources could get so concentrated that the common researcher can\u2019t use them. Open access is super vital for the scientific field to make progress.\u201d<\/p>\n<\/p><\/div>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Artificial intelligence is already proving it may well speed up drug development and improve our understanding of disease. But to show AI into novel treatments we want to get the most recent, strongest models into the hands of scientists. The issue is that almost all scientists aren\u2019t machine-learning experts. Now the corporate OpenProtein.AI helps scientists […]<\/p>\n","protected":false},"author":1,"featured_media":321509,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[1736,50797,584,182,395,50796,898],"class_list":["post-321508","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-aidriven","tag-biologists","tag-bringing","tag-mit","tag-news","tag-proteindesign","tag-tools"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/ebiztoday.news\/index.php\/wp-json\/wp\/v2\/posts\/321508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ebiztoday.news\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ebiztoday.news\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ebiztoday.news\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ebiztoday.news\/index.php\/wp-json\/wp\/v2\/comments?post=321508"}],"version-history":[{"count":2,"href":"https:\/\/ebiztoday.news\/index.php\/wp-json\/wp\/v2\/posts\/321508\/revisions"}],"predecessor-version":[{"id":321511,"href":"https:\/\/ebiztoday.news\/index.php\/wp-json\/wp\/v2\/posts\/321508\/revisions\/321511"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ebiztoday.news\/index.php\/wp-json\/wp\/v2\/media\/321509"}],"wp:attachment":[{"href":"https:\/\/ebiztoday.news\/index.php\/wp-json\/wp\/v2\/media?parent=321508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ebiztoday.news\/index.php\/wp-json\/wp\/v2\/categories?post=321508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ebiztoday.news\/index.php\/wp-json\/wp\/v2\/tags?post=321508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}